Renovascular disease: Effect of ACE gene deletion polymorphism and endovascular revascularization

Journal of Vascular Surgery

Volumn 39, Issue 1, 2004, Pages 140-147

  Pizzolo, Francesca ^a,b   Mansueto, Giancarlo ^a,b   Minniti, Salvatore ^a,b   Mazzi, Mariangela ^a,b   Trabetti, Elisabetta ^a,b   Girelli, Domenico ^a,b   Corrocher, Roberto ^a,b   Olivieri, Oliviero ^a,b  

^a University of Verona ^*

^b UNIVERSITY OF VERONA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE;

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD PRESSURE REGULATION; CONSERVATIVE TREATMENT; CONTROLLED STUDY; DNA POLYMORPHISM; ENDOVASCULAR SURGERY; FEMALE; FOLLOW UP; GENE DELETION; HUMAN; INTERMETHOD COMPARISON; KIDNEY ARTERY STENOSIS; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PREDICTION; PRIORITY JOURNAL; RECURRENT DISEASE; RETROSPECTIVE STUDY; REVASCULARIZATION; STENT; SURGICAL MORTALITY; TREATMENT OUTCOME; TREATMENT PLANNING;

EID: 0347595307     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0741-5214(03)01018-8     Document Type: Article

References (33)

1. Preston RA, Epstein M. Ischemic renal disease: emerging cause of chronic renal failure and end stage renal disease. J Hypertens 1997;15: 1365-77.
2. Scoble JE, Sweny P, Stansby J, Hamilton G. Patients with atherosclerotic renovascular disease presenting to a renal unit: an audit of outcome. Postgrad Med J 1993;69:461-5.
3. Baboolal K, Evans C, Moore RH. Incidence of end-stage renal disease in medically treated patients with severe bilateral atherosclerotic renovascular disease. Am J Kidney Dis 1998;31:971-7.
4. Caps MT, Perissinotto C, Zierler RE, Polissar NL, Bergelin RO, Tullis MJ, et al. Prospective study of atherosclerotic disease progression in the renal artery. Circulation 1998;98:2866-72.
5. Caps MT, Zierler RE, Polissar NL, Bergelin RO, Beach KW, Cantwell-Gab K, et al. Risk of atrophy in kidneys with atherosclerotic renal artery stenosis. Kidney Int 1998;53:735-42.
6. Mailloux LU, Napolitano B, Bellucci AG, Vernace M, Wilkes BM, Mossey RT. Renal vascular disease causing end-stage renal disease: incidence, clinical correlates, and outcomes; a 20 year clinical experience. Am J Kidney Dis 1994;4:622-9.
7. Conlon PJ, Little MA, Pieper K, Mark DB. Severity of vascular disease predicts mortality in patients undergoing coronary angiography. Kidney Int 2001;60:1490-7.
8. Watson PF, Hajipetrou P, Cox SV, Piemonte TC, Eisenhauer AC. Effect of renal artery stenting on renal function and size in patients with atherosclerotic renovascular disease. Circulation 2000;102:1671-7.
9. Tuttle KR, Raabe RD. Endovascular stents for renal artery revascularization. Curr Opin Nephrol Hypertens 1998;7:695-701.
10. Lederman RG, Mendelsohn FO, Santos R, Phillips HR, Stack RS, Crowley JJ. Primary renal artery stenting: characteristics and outcomes after 363 procedures. Am Heart J 2001;142:314-23.
11. Ramos F, Kotliar C, Alvarez D, Baglivo H, Raffaelle P, Londero H, et al. Renal function and outcome of PTRA and stenting for atherosclerotic renal artery stenosis. Kidney Int 2003;63:276-82.
12. Plouin PF, Chatellier G, Darné B, Raynaud A. Blood pressure outcome of angioplasty in atherosclerotic renal artery stenosis. Hypertension 1998;31:823-9.
13. Jaarsveld BC, Krijen P, Pieterman H, Derkx FHM, Deinum J, Postma CT, et al. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis. N Engl J Med 2000;342:1007-14.
14. Webster J, Marshall F, Abdalla M, Dominiczak A, Edwards R, Isles CG, et al. Randomised comparison of percutaneous angioplasty vs continued medical therapy for hypertensive patients with atheromatous renal artery stenosis. Scottish and Newcastle Renal Artery Stenosis Collaborative Group. J Hum Hypertens 1998;12:329-35.
15. Missouris CG, Barley G, Jefferey S, Carter ND, Singer DRJ, MacGregor GA. Genetic risk for renal artery stenosis: association with deletion polymorphism in angiotensin I-converting enzyme gene. Kidney Int 1996;49:534-7.
16. Olivieri O, Trabetti E, Grazioli S, Stranieri C, Friso S, Girelli D, et al. Genetic polymorphism of the renin-angiotensin system and atheromatous renal artery stenosis. Hypertension 1999;34:1097-1100.
17. Olivieri O, Grazioli S, Pizzolo F, Stranieri C, Trabetti E, Beltrame F, et al. Different impact of deletion polymorphism of ACE gene in renal and coronary atherosclerotic disease. J Hypertens 2002;20:37-43.
18. Losito A, Parente B, Cao PG, Jeffery S, Afzal AR. ACE gene polymorphism and survival in atherosclerotic renovascular disease. Am J Kidney Dis 2000;35:211-5.
19. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F. An insertion-deletion polymorphism in the angiotensin I-concerting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990;86:1343-6.
20. Mann SJ, Pickering TG. Detection of renovascular hypertension: state of the art. Ann Intern Med 1992;117:845-53.
21. Henry M, Amor M, Henry I, Ethevenot G, Allaoui M, Tricoche O, et al. Stent placement in the renal artery: three year experience with the Palmaz stent. J Vasc Interv Radiol 1996;7:343-50.
22. Dorros G, Jaff M, Mathiak L, Dorros II, Lowe A, Murphy K, et al. Four year follow-up of Palmaz-Schatz stent revascularization as treatment for atherosclerotic renal artery stenosis. Circulation 1998;98:642-7.
23. Colon PJ, Athirakul K, Kovalik E, Schwab SJ, Crowley J, Stack R, et al. Survival in renal vascular disease. J Am Soc Nephrol 1998;9:252-6.
24. Hoffman O, Carreres T, Sapoval MR, Auguste MC, Beyssen BM, Raynaud AC, et al. Ostial renal artery stenosis angioplasty: immediate and mid-term angiographic and clinical results. J Vasc Interv Radiol 1998;9:65-73.
25. Williamson WK, Abou-Zamzam AM, Moneta GL, Yeager RA, Edwards JM, Taylor LM, et al. Prophylactic repair of renal artery stenosis is not justified in patients who required infrarenal aortic reconstruction. J Vasc Surg 1998;28:14-22.
26. Tan WA, Wholey MH. The effect of balloon angioplasty on hypertension in atherosclerotic renal artery stenosis [letter]. N Engl J Med 2000;343:438-9.
27. Mann SJ, Pecker MS. Reply [letter]. N Engl J Med 2000;343:439.
28. Leertouwer TC, Gussenhoven EJ, Bosch JL, Van Jaarsveld BC, Van Dijk LC, Deinum J, et al. Stent placement for renal artery stenosis: where do we stand? A meta-analysis. Radiology 2000;216:78-85.
29. Harden PN, MacLeod MJ, Rodger RSC, Baxter GM, Connel JMC, Dominiczak AF, et al. Effect of renal-artery stenting on progression of renovascular renal failure. Lancet 1997;349:1133-6.
30. Blum U, Krumme B, Flugel P, Gabelmann A, Lchnert T, Buitrago-Tellez C, et al. Treatment of renal artery stenoses with vascular endoprotheses after unsuccessful balloon angioplasty. N Engl J Med 1997; 336:459-65.
31. Safian RD, Textor FC. Renal artery stenosis. N Engl J Med 2001;344: 431-42.
32. Higashi Y, Sasaki S, Nakagawa K, Matsuura H, Oshima T, Chayama K. Endothelial function and oxidative stress in renovascular hypertension. N Engl J Med 2002;346:1954-62.
33. Minuz P, Patrignani P, Gaino S, Degan M, Menapace L, Tommasoli R, et al. Increased oxidative stress and platelet activation in patients with hypertension and renovascular disease. Circulation 2002;106:2800-5.